volume 26, issue 6, P321-333 2018
DOI: 10.1007/s12471-018-1113-5
View full text
|
Sign up to set email alerts
|
Share

Abstract: The optimal duration of dual antiplatelet therapy (DAPT) for stable coronary artery disease and acute coronary syndrome is a complex decision. We review current literature on standard duration DAPT versus short duration DAPT (6 months or shorter) or extended duration DAPT (>12 months) after percutaneous coronary intervention with drug-eluting stent placement, and prolonged treatment after 12 months in acute coronary syndrome. Current guideline recommendations are summarised, including the use of risk scores fo…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

1
4
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals